Skip to main content

Table 1 Clinical and serum biochemical parameters of subjects

From: Metabolic analysis of early nonalcoholic fatty liver disease in humans using liquid chromatography-mass spectrometry

  NAFLD
(n = 112)
Control
(n = 112)
P value
Gender (M/F) 68/44 62/50  
Age 46 ± 14 41 ± 15 0.538
Height (cm) 169.42 ± 8.73 170.59 ± 8.07 0.615
Weight (kg) 77.55 ± 13.49 62.37 ± 8.05 0.001**
BMI (kg/m2) 27.1(24–28.55) 21.46(20.57–22.54) 0.001**
Systolic pressure (mmHg) 125.41(120–130) 123.59(115–132) 0.375
Diastolic pressure (mmHg) 79.74(75–85) 77.63(74–81) 0.183
Waist circumference (cm) 91.75 ± 11.76 72.04 ± 5.96 0.001
Heart rate (BPM) 68.68 ± 5.09 68.80 ± 4.88 0.851
Smoking (n) 62 83 0.154
Drinking (n)    0.916
 None 10 6  
 Light 38 43  
 Moderate 64 63  
Blood glucose (mmol/L) 5.12 ± 0.35 5.21 ± 0.42 0.38
TB (umol/L) 12.74 ± 2.54 12.89 ± 3.62 0.862
DB (umol/L) 2.32 ± 0.5 2.23 ± 0.95 0.669
TP (g/L) 73.52 ± 4.71 73.11 ± 5.4 0.769
ALB (umol/L) 41.85 ± 2.99 41.37 ± 5.46 0.689
CHE (U/L) 8400.78 ± 1353.66 7694.52 ± 1640.95 0.09
ALT (U/L) 20.67 ± 11.67 28.04 ± 19.13 0.093
AST (U/L) 23.93 ± 6.49 27.7 ± 13.02 0.183
ALP (U/L) 76.96 ± 18.08 84.33 ± 22.15 0.186
γ-GT(U/L) 23.74 ± 11.8 31.59 ± 22.75 0.118
TC (mmol/L) 5.67 ± 1.22 4.57 ± 0.8 0.001**
TG (mmol/L) 0.83 ± 0.96 1.24 ± 0.56 0.008*
HDL-C (mmol/L) 0.98 ± 0.18 1.49 ± 0.35 0.002*
LDL-C (mmol/L) 4.89 ± 0.73 3.65 ± 1.01 0.002*